A view of the new research, development, and biomanufacturing facility from the intersection of Grays Ferry Avenue and 34th Street on the Pennovation Works property (Photo courtesy of Longfellow Real Estate Partners)
With the flourishing cell and gene therapy programs at Penn, as well as the successes and future promise of mRNA as a therapeutic, the lab and biomanufacturing facilities will offer an opportunity for biotech companies to remain in Philadelphia, adjacent to Penn’s campus, as they expand.